KiOmed Pharma
KiOmed Pharma, based in Belgium, is a biotech company that focuses on the development, manufacture and distribution of safe and effective medical devices based on KiOmedine CM-Chitosan, our innovative and exclusive animal-free bioresorbable biopolymer. Through a series of comparative, pre-clinical and clinical studies, KiOmed Pharma repeatedly demonstrated that its exclusive technology KiOmedine CM-Chitosan offers unique and sustainable attributes in comparison with competitive products. Our multidisciplinary team experts continually strive to advance innovative solutions to address unmet needs in the treatment of invalidating OsteoArthritis symptoms, dry eye disease and skin aging pathologies.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Monitoring
- Market Focus:
- Globally (various continents)
Innovative and patented technology
KiOmed Pharma's innovative pipeline is based on a solid building block exclusive technology: KiOmedine®, a medical-grade highly pure natural chitosan-derivative.
The patented technology KiOmedine® CM-Chitosan offers competitive advantages thanks to its immune-compatibility and unique structure. Our scientific team has conducted a large number of safety and efficacy studies to demonstrate the unrivaled properties of our KiOmedine® CM-Chitosan technology in various applications :
- Excellent lubrication properties
- Outstanding scavenging capacity
- High ability to protect tissues against oxydative stress
KiOmedine® CM-Chitosan brings high clinical value to therapeutic solutions and is a technology of choice, suitable for injectable formulations and implantable devices.
KiOmedine® brings unique clinical value in hig...
KiOmedine® brings unique clinical value in high impact pathologies and major social burdens
Invalidating OsteoArthritis
KioMedinevsone is the first soft implant intended to treating OsteoArthritis, an invalidating pathology that affects more than 100 millions of patients worldwide.
The unique character of KiOmedine® resides in its innovative chemical design and non-animal origin that allow developing safe medical devices to offer high clinical efficacy thanks to tunable attributes such as lubrication and combating free-radical species.
Skin Aging
Thanks to free radical scavenging, KiOmedine®-based dermal fillers provide tunable tissues filling properties with unique skin protection and hydration while stimulating collagen synthesis.
Dry Eye Disease
Thanks to its unique hydrating and lubricating properties, as well as its ability to protect tissues against oxidative stress, KiOmedine® is a component of choice in eyedrops formulations or for more innovative treatments of the posterior segment.
From years of research to commercial stage
Through a series of comparative, pre-clinical and clinical studies, KiOmed Pharma repeatedly demonstrated that its exclusive technology KiOmedine® CM-Chitosan offers unique and sustainable attributes in comparison with competitive products. Our multidisciplinary team experts continually strive to advance innovative solutions to address unmet needs in the treatment of invalidating OsteoArthritis symptoms, dry eye disease and skin aging pathologies.